China Cord Blood - 18 Year Stock Price History | CORBF
Historical daily share price chart and data for China Cord Blood since 2007 adjusted for splits and dividends. The latest closing stock price for China Cord Blood as of May 22, 2025 is 0.85.
- The all-time high China Cord Blood stock closing price was 14.53 on August 25, 2017.
- The China Cord Blood 52-week high stock price is 2.00, which is 135.3% above the current share price.
- The China Cord Blood 52-week low stock price is 0.25, which is 70.6% below the current share price.
- The average China Cord Blood stock price for the last 52 weeks is 1.20.
| China Cord Blood Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 0.9655 | 1.0100 | 1.2000 | 0.2500 | 0.8500 | -43.33% |
| 2024 | 1.3671 | 1.2800 | 2.0000 | 1.0000 | 1.5000 | 22.95% |
| 2023 | 1.9934 | 2.9900 | 2.9900 | 0.9000 | 1.2200 | -59.20% |
| 2022 | 3.1790 | 4.3200 | 4.5500 | 2.0500 | 2.9900 | -28.64% |
| 2021 | 4.6831 | 4.1200 | 6.2200 | 3.8000 | 4.1900 | 12.94% |
| 2020 | 3.6419 | 4.9700 | 5.2200 | 2.5600 | 3.7100 | -25.80% |
| 2019 | 5.7924 | 6.2000 | 7.6000 | 4.2000 | 5.0000 | -22.48% |
| 2018 | 8.3596 | 9.8715 | 11.7528 | 5.7100 | 6.4500 | -34.53% |
| 2017 | 9.0582 | 5.7625 | 14.5251 | 5.5645 | 9.8517 | 62.58% |
| 2016 | 5.5360 | 6.1883 | 6.2774 | 4.3763 | 6.0596 | -3.92% |
| 2015 | 5.8489 | 4.6041 | 7.5744 | 4.2278 | 6.3071 | 40.93% |
| 2014 | 4.4992 | 3.9803 | 5.6437 | 3.7823 | 4.4754 | 12.72% |
| 2013 | 3.3067 | 2.7228 | 4.3664 | 2.5644 | 3.9704 | 53.64% |
| 2012 | 2.6945 | 2.5149 | 3.1684 | 2.2575 | 2.5842 | -1.51% |
| 2011 | 3.0658 | 3.7625 | 3.9122 | 2.0100 | 2.6238 | -34.08% |
| 2010 | 5.1510 | 6.2972 | 6.5843 | 3.1684 | 3.9802 | -38.16% |
| 2009 | 6.1940 | 5.4457 | 12.7231 | 5.4457 | 6.4358 | 18.18% |
| 2008 | 5.6341 | 5.5447 | 5.8318 | 5.3467 | 5.4457 | -1.26% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $0.000B |
| Global Cord Blood Corporation operates as a life sciences company. It provides umbilical cord blood stem cells from newborn babies and offers laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company also operates as cord blood banking operator. Global Cord Blood Corporation, formerly known as China Cord Blood Corporation, is based in Hong Kong, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.174B | 25.17 |
| Elevance Health (ELV) | United States | $86.874B | 11.21 |
| CVS Health (CVS) | United States | $76.179B | 9.47 |
| Cencora (COR) | United States | $56.230B | 19.56 |
| DiDi Global (DIDIY) | China | $23.297B | 35.36 |
| Natera (NTRA) | United States | $20.821B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.571B | 13.31 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.522B | 0.00 |
| CochLear (CHEOY) | Australia | $11.391B | 0.00 |
| Revvity (RVTY) | United States | $10.665B | 18.35 |
| ICON (ICLR) | Ireland | $10.255B | 9.53 |
| Viatris (VTRS) | United States | $9.976B | 3.43 |
| Doximity (DOCS) | United States | $9.570B | 44.57 |
| Avantor (AVTR) | United States | $8.763B | 12.73 |
| HealthEquity (HQY) | United States | $8.657B | 42.59 |
| Medpace Holdings (MEDP) | United States | $8.422B | 22.37 |
| Sonic Healthcare (SKHHY) | Australia | $8.157B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.660B | 13.05 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $3.994B | 36.97 |
| Bausch + Lomb (BLCO) | Canada | $3.976B | 23.44 |
| Sotera Health (SHC) | United States | $3.480B | 19.77 |
| Surgery Partners (SGRY) | United States | $2.896B | 37.67 |
| Alignment Healthcare (ALHC) | United States | $2.867B | 0.00 |
| Concentras Parent (CON) | United States | $2.744B | 15.86 |
| Organon (OGN) | United States | $2.259B | 2.40 |
| Ardent Health Partners (ARDT) | United States | $2.117B | 9.02 |
| GeneDx Holdings (WGS) | United States | $1.921B | 73.99 |
| Premier (PINC) | United States | $1.910B | 14.50 |
| Progyny (PGNY) | United States | $1.791B | 39.42 |
| PACS (PACS) | United States | $1.494B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.364B | 27.29 |
| Teladoc Health (TDOC) | United States | $1.211B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.200B | 9.13 |
| Establishment Labs Holdings (ESTA) | $1.066B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.953B | 14.88 |
| Agilon Health (AGL) | United States | $0.911B | 0.00 |
| Nutex Health (NUTX) | United States | $0.901B | 13.61 |
| AMN Healthcare Services Inc (AMN) | United States | $0.830B | 7.77 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.614B | 4.14 |
| InnovAge Holding (INNV) | United States | $0.543B | 0.00 |
| LifeMD (LFMD) | United States | $0.523B | 0.00 |
| Enhabit (EHAB) | United States | $0.520B | 42.75 |
| Auna S.A (AUNA) | Luxembourg | $0.505B | 11.37 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| SBC Medicals (SBC) | United States | $0.398B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.388B | 0.00 |
| Oncology Institute (TOI) | United States | $0.226B | 0.00 |
| Beauty Health (SKIN) | United States | $0.217B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.214B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.137B | 22.33 |
| OncoCyte (OCX) | United States | $0.098B | 0.00 |
| So-Young (SY) | China | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.071B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.052B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.022B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |